| 000 | 01707 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515023848.0 | ||
| 264 | 0 | _c20060608 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1526-744X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSasak, C | |
| 245 | 0 | 0 |
_aSupporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient. _h[electronic resource] |
| 260 |
_bNephrology nursing journal : journal of the American Nephrology Nurses' Association _cDec 2000 |
||
| 300 |
_a612-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnemia, Iron-Deficiency _xdrug therapy |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 | _aErythrocyte Indices |
| 650 | 0 | 4 |
_aErythropoiesis _xdrug effects |
| 650 | 0 | 4 |
_aErythropoietin _xpharmacology |
| 650 | 0 | 4 |
_aFerritins _xblood |
| 650 | 0 | 4 |
_aHematinics _xpharmacology |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 |
_aHemoglobins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aIron Compounds _xpharmacology |
| 650 | 0 | 4 |
_aIron Overload _xetiology |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 | _aNurse's Role |
| 650 | 0 | 4 | _aNursing Assessment |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 650 | 0 | 4 | _aSafety Management |
| 650 | 0 | 4 |
_aTransferrin _xmetabolism |
| 773 | 0 |
_tNephrology nursing journal : journal of the American Nephrology Nurses' Association _gvol. 27 _gno. 6 _gp. 612-5 |
|
| 999 |
_c16251577 _d16251577 |
||